Skip to content

PRINCIPIA BIOPHARMA INC.

CIK 0001510487

← back to feed
Revenue (TTM)
$80M
Q2 Jul 2020
Net Income (TTM)
−$36.87M
+40.3% YoY Q2 Jul 2020
EPS Diluted (TTM)
−$0.91
+14.0% YoY Q2 Jul 2020
Gross Margin
—
Q2 Jul 2020
Operating Margin
-51.9%
Q2 Jul 2020
Net Margin
-46.1%
Q2 Jul 2020
Free Cash Flow (TTM)
−$44.72M
Q2 Jul 2020
Cash
$170.49M
Q2 Jul 2020
Total Debt
—
Q2 Jul 2020
Shares Outstanding
33.21M sh
Q2 Jul 2020

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings